Company profile for ProKidney

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful impr...
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3929 Westpoint Blvd. Suite G Winston-Salem, NC 27103
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/10/3185075/0/en/ProKidney-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Regulatory-and-Clinical-Updates.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3182854/0/en/ProKidney-Presents-Full-Results-from-the-Phase-2-REGEN-007-Trial-of-Rilparencel-at-the-American-Society-of-Nephrology-Kidney-Week-2025.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/10/29/3176322/0/en/ProKidney-to-Participate-in-Two-Upcoming-Conferences-Guggenheim-Healthcare-Innovation-Conference-and-the-Jefferies-Global-Healthcare-Conference.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/10/20/3169257/0/en/ProKidney-Announces-Two-Abstracts-Selected-for-Presentation-at-the-American-Society-of-Nephrology-s-Kidney-Week-2025.html

GLOBENEWSWIRE
20 Oct 2025

https://www.globenewswire.com/news-release/2025/08/27/3139909/0/en/ProKidney-to-Participate-in-Two-Upcoming-Conferences-the-Citi-Biopharma-Back-to-School-Conference-and-the-Morgan-Stanley-Global-Healthcare-Conference.html

GLOBENEWSWIRE
27 Aug 2025

https://www.globenewswire.com/news-release/2025/08/12/3132100/0/en/ProKidney-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Regulatory-and-Clinical-Updates.html

GLOBENEWSWIRE
12 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty